MERIT MEDICAL SYSTEMS INC

For the period ended Jun 30, 2025. Filed Jul 30, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Jul 30, 2025

MMSI$88.42+1.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(In thousands)


· June 30, · December 31,
ASSETS · 2025 · 2024
	(unaudited)
Current assets: · ·
Cash and cash equivalents	$341,819	$376,715
Trade receivables — net of allowance for credit losses — 2025 — $10,108 and 2024 — $9,729	204,162	190,243
Other receivables	14,292	16,588
Inventories	323,309	306,063
Prepaid expenses and other current assets	30,162	28,544
Prepaid income taxes	3,543	3,286
Income tax refund receivables	5,785	2,335
Total current assets	923,072	923,774

Property and equipment:
Land and land improvements	30,467	25,846
Buildings	198,505	192,296
Manufacturing equipment	353,119	340,864
Furniture and fixtures	64,102	61,321
Leasehold improvements	60,649	58,770
Construction-in-progress	74,850	58,673
Total property and equipment	781,692	737,770
Less accumulated depreciation	(371,707)	(351,605)
Property and equipment — net	409,985	386,165

Other assets:
Intangible assets:
Developed technology — net of accumulated amortization — 2025 — $414,713 and 2024 — $377,993	489,975	431,766
Other — net of accumulated amortization — 2025 — $90,872 and 2024 — $85,343	72,183	66,499
Goodwill	504,555	463,511
Deferred income tax assets	16,243	16,044
Right-of-use operating lease assets	89,279	65,508
Other assets	80,753	65,336
Total other assets	1,252,988	1,108,664

Total assets	$2,586,045	$2,418,603


See condensed notes to consolidated financial statements.	(continued)

CONSOLIDATED BALANCE SHEETS

(In thousands)


· June 30, · December 31,
LIABILITIES AND STOCKHOLDERS’ EQUITY · 2025 · 2024
	(unaudited)
Current liabilities: · · ·
Trade payables	$69,066	$68,502
Accrued expenses	140,204	134,077
Short-term operating lease liabilities	10,262	10,331
Income taxes payable	6,040	3,492
Total current liabilities	225,572	216,402

Long-term debt	731,795	729,551
Deferred income tax liabilities	26,925	240
Liabilities related to unrecognized tax benefits	2,169	2,118
Deferred compensation payable	19,800	19,197
Deferred credits	1,450	1,502
Long-term operating lease liabilities	78,496	54,783
Other long-term obligations	11,790	15,451
Total liabilities	1,097,997	1,039,244

Commitments and contingencies

Stockholders' equity:
Preferred stock — 5,000 shares authorized; no shares issued as of June 30, 2025 and December 31, 2024	—	—
Common stock, no par value — 100,000 shares authorized; issued and outstanding as of June 30, 2025 - 59,218 and December 31, 2024 - 58,743	734,841	703,219
Retained earnings	758,269	695,541
Accumulated other comprehensive loss	(5,062)	(19,401)
Total stockholders’ equity	1,488,048	1,379,359

Total liabilities and stockholders’ equity	$2,586,045	$2,418,603


See condensed notes to consolidated financial statements.	(concluded)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.